Get complete access to comprehensive company data for Agappe Diagnostics Limited.
Complete Report
One-time • Full access
Credit Plan
Pay as you go • Instant
Processing your request...
Downloading your report...
Success
Request Company Screening
Agappe Diagnostics Limited
Once your screening request is processed, you will receive a notification and the complete report will be available in PDF format for download from your account dashboard.
₹ 7.00 cr
₹ 6.13 cr
18 Jun 1998
31 Mar 2024
Agappe Diagnostics Limited is an Indian public limited company incorporated on 18 Jun 1998. The company's registered office is situated in Mumbai, Maharashtra, India.
The current status of Agappe Diagnostics Limited is Active. The company has filed its annual returns and financial statements up to 31 Mar 2024 (FY 2023-2024).
Agappe Diagnostics Limited is a company limited by shares with an authorized capital of ₹7.00 cr and a paid-up capital of ₹6.13 cr as per the records maintained by the Ministry of Corporate Affairs (MCA).
Agappe Diagnostics Limited has 9 directors and 1 signatories. The Key Managerial Personnel (KMP) at Agappe Diagnostics Limited include Sreevidya P M as Company Secretary. The directors of the company include Joseph John, Thomas Jacob Kalappila, Thomas John, Sangeeta Joseph.
The registered office of Agappe Diagnostics Limited is located at Office Nos 401-402, Jaisingh Business Centre, Sahar Road, Andheri (East) Mumbai Maharashtra 400099 India in Mumbai, Maharashtra, India.
- CIN/LLPIN/FCRN: U24239MH1998PLC115413
- Legal Name: Agappe Diagnostics Limited
- ROC Code: Roc Mumbai
- Company No.: 115413
- Company Category: Company Limited By Shares
- Company Sub Category: Non-Government Company
- Company Class: Public
- Listing Status: Unlisted
- Industry: Healthcare
- Date of AGM: 27 Sep 2024
🔒 14.3%
(FY 202_)🔒 8.9%
(FY 202_)🔒 12.7%
(FY 202_)🔒 9.5%
(FY 202_)🔒 11.8%
(FY 202_)🔒 15.2%
(FY 202_)🔒 10.6%
(FY 202_)🔒 13.4%
(FY 202_)
Financial Performance Overview
| Financial Metric | FY 2023 | Growth | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | 12,45,67,890 | +191.42% | 4,26,78,123 | 3,89,45,234 | 2,98,12,456 | 2,15,67,890 |
| Revenue from Operations | 11,98,45,678 | +176.82% | 4,32,10,987 | 3,78,90,123 | 2,89,45,678 | 2,10,23,456 |
| Total Assets | 45,67,89,012 | +61.07% | 28,34,56,789 | 24,56,78,901 | 19,87,65,432 | 16,54,32,109 |
| Profit or Loss | -1,23,45,678 | 24.56% | 4,32,109 | 2,15,678 | 1,89,234 | 1,23,456 |
| Net Worth | 12,34,56,789 | 85.66% | 85,67,89,012 | 78,90,12,345 | 65,43,21,098 | 54,32,10,987 |
| EBITDA | 2,34,56,789 | +6604.87% | 3,49,012 | 2,10,987 | 1,56,789 | 98,765 |
| Past Director Details of Agappe Diagnostics Limited |
|---|
Frequently Asked Questions
- damodaran madhavi vasudevan
- joseph john
- joseph vadakkekara antony
- mary baby meleth
- meena thomas
- rhema elizabeth thomas
- sangeeta joseph
- sreevidya p m
- thomas jacob kalappila
- thomas john